Overview
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
Description
To evaluate the safety for 60 months after a single dose of Hearticellgram-AMI in patients with Acute Myocardial Infarction.
Eligibility
Inclusion Criteria:
- Those who had administered Hearticellgram-AMI
- Those who voluntarily agreed in writing to participate in this investigation
Exclusion Criteria:
\-